CHINA TOPIX

11/02/2024 04:11:46 pm

Make CT Your Homepage

Breast Cancer Drug Perjeta Can Prolong Cancer Patient Lives by 16 Months

Roche's Perjeta (pertuzumab) can lengthen the survival of HER2 breast cancer patients by 16 months

Breast Cancer Drug Perjeta Can Prolong Cancer Patients' Lives by 16 Months

According to a new study, Roche's Perjeta along with chemotherapy and Herceptin can prolong breast cancer patients' lives.

Real Time Analytics